Dennis Bourdette, Ruth Whitham. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Controlled Clinical Trials as TopicHumansImmunotherapyMitoxantrone/adverse effectsMitoxantrone/therapeutic useMultiple Sclerosis/drug therapyMultiple Sclerosis/immunologyMultiple Sclerosis, Relapsing-Remitting/drug therapyTreatment Outcome
Substances: See more » Mitoxantrone
Year: 2010 PMID: 20439842 DOI: 10.1212/WNL.0b013e3181dc1b36
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910